NCT00406705

Brief Summary

The purpose of this study is to examine whether breathing helium-hyperoxia during exercise in a pulmonary rehabilitation program can improve the exercise tolerance and health related quality of life of patients with Chronic Obstructive Pulmonary Disease (COPD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at below P25 for phase_2 chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Mar 2005

Typical duration for phase_2 chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2005

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

November 29, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 4, 2006

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2007

Completed
Last Updated

May 4, 2007

Status Verified

March 1, 2007

First QC Date

November 29, 2006

Last Update Submit

May 3, 2007

Conditions

Keywords

Exercise ToleranceDyspneaRehabilitationHelium

Outcome Measures

Primary Outcomes (1)

  • Constant-load exercise tolerance after 6 weeks of exercise rehabilitation

Secondary Outcomes (3)

  • Maximum oxygen consumption after 6 weeks of exercise rehabilitation

  • Quality of Life measured after 6 weeks of exercise rehabilitation

  • Dyspnea at an isotime during constant-load exercise after 6 weeks of exercise rehabilitation

Interventions

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • FEV1/FVC\<70% predicted;
  • FEV1\<70% predicted;
  • RV\>140% predicted.

You may not qualify if:

  • Cardiovascular contraindications to exercise;
  • Musculoskeletal abnormalities that limit exercise tolerance;
  • SpO2\<85% during a constant work rate test;
  • On supplemental oxygen.
  • Exacerbation within the last month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Caritas Centre for Lung Health

Edmonton, Alberta, T5K 0L4, Canada

Location

Related Publications (2)

  • Eves ND, Petersen SR, Haykowsky MJ, Wong EY, Jones RL. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Oct 1;174(7):763-71. doi: 10.1164/rccm.200509-1533OC. Epub 2006 Jul 13.

    PMID: 16840742BACKGROUND
  • Eves ND, Sandmeyer LC, Wong EY, Jones LW, MacDonald GF, Ford GT, Petersen SR, Bibeau MD, Jones RL. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD. Chest. 2009 Mar;135(3):609-618. doi: 10.1378/chest.08-1517. Epub 2008 Nov 18.

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveEmphysemaLung DiseasesBronchitis, ChronicDyspnea

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Neil D Eves, PhD

    University of Calgary, AB, Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 29, 2006

First Posted

December 4, 2006

Study Start

March 1, 2005

Study Completion

January 1, 2007

Last Updated

May 4, 2007

Record last verified: 2007-03

Locations